Frontlight ResearchEarly access
Gastric and oesophageal cancer trials in India
6 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 2/3Not yet taking people in IndiaA Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
- Where
- Delhi, Mumbai, Nashik, Puducherry, Pune
- Age
- 18 years and over
- People
- 690 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07221149 · EU 2025-523263-37-00 - Phase 3Taking peopleA Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
- Where
- Ansārinagar, Bangalore, Delhi, Hyderabad, Kolkata, Mumbai, Varanasi
- Age
- 18 years and over
- People
- 840 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06764875 · EU 2024-512583-57-00 - Phase 3Taking peopleSonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
- Where
- Ahmedabad, Bhubaneswar, Hyderabad, Kolkata, Mohali, Mumbai, New Delhi, Varanasi, Vijayawada, Visakhapatnam
- Age
- 18 years and over
- People
- 2,130 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07431281 · EU 2024-519787-40-00 - No phaseTaking peopleA Multicentre Observational Cross-Sectional Study of The Gastric Precancerous Epithelial Pathway Using High-Definition Endoscopy And Histopathology In India
- Where
- Hyderabad
- Age
- 40 years and over
- People
- 4,000
- Run by
- Asian Institute of Gastroenterology, India
See details and how to joinNCT07486518 - Phase 1Taking peopleA Study Evaluating the Safety and Efficacy of AUR107 in Patients With Relapsed Advanced Malignancies (SHAKTI-1)
- Where
- Ahmedabad, Bangalore, Bhubaneswar, Chandigarh, Chhatrapati Sambhajinagar, Hyderabad, Kolhāpur, Kolkata, Mysore, Nagpur, Nashik, Navi Mumbai, New Delhi, Puducherry, Pune, Rohtak, Surat, Thane, Vijayawada, Visakhapatnam
- Age
- 18 years and over
- People
- 50
- Run by
- Aurigene Discovery Technologies Limited
See details and how to joinNCT05865002 - No phaseTaking peopleDistribution of Lymph Node Metastases in Esophageal Carcinoma
- Where
- Mumbai
- Age
- 18 years and over
- People
- 5,000 worldwide
- Run by
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
See details and how to joinNCT03222895